Protein folding, molecule generation and AI-native drug pipelines. The lab bench is going computational.
181 articles
The article signals a new iteration phase for the ActRⅡ pathway, focusing on advanced muscle-building and fat-loss applications. This marks a significant shift in the biotech sector's approach to metabolic health.
钛媒体 · 81d ago
The world’s largest biopharmaceutical royalty buyer has established its first Asia-Pacific headquarters in Hong Kong. This move aims to capitalize on the surge in out-licensing deals by mainland Chinese biotech firms seeking alternative capital.
SCMP Technology · 81d ago
The pharmaceutical sector is experiencing a significant resurgence, described as an inevitable outcome rather than a random event. This suggests underlying structural changes or breakthroughs driving the industry's recovery.
钛媒体 · 81d ago
Medtech firm Tissium secured €60M to bring its FDA-cleared, light-cured nerve repair glue to the US market. The product aims to replace traditional surgical sutures for nerve repair.
The Next Web (TNW) · 87d ago
A French startup has engineered a biodegradable polymer material designed to facilitate nerve regeneration following surgery or physical trauma. This material aims to provide a structural scaffold that improves recovery outcomes.
Wired · 87d ago
UPS 宣布投資 4800 萬美元建設 27 個溫控貨運設施，以應對生物製劑物流需求的激增。這些設施支援多種溫度範圍，優化了空運與陸運之間的儲存流程。
The Next Web (TNW) · 89d ago
A recent study suggests that GLP-1 receptor agonists, commonly used for weight loss, may correlate with a reduction in aggressive behavior and violent crime. This finding adds a new dimension to the societal impact of these widely used medications.
cnBeta (Full RSS) · 91d ago
Researchers are evaluating a vaccine developed in 2011 to determine its efficacy against the current Bundibugyo Ebola outbreak in Congo. The vaccine has remained largely unused for over a decade.
Wired · 92d ago
Researchers at the Monell Chemical Senses Center found that fructose and glucose communicate differently with the brain via gut-brain pathways. Fructose is less effective at signaling satiety, which may influence dietary habits and caloric intake.
cnBeta (Full RSS) · 97d ago
This article examines the privacy and data usage implications hidden within the terms of service for consumer DNA testing kits. It warns users about how their sensitive biological data may be shared or utilized by third parties.
ZDNet AI · 98d ago
A former J&J R&D executive has successfully led a high-profile team to complete a record-breaking biotech IPO. This move signals significant capital movement in the life sciences sector.
钛媒体 · 99d ago
Industry analysts predict that top Chinese biotechnology firms will transition from drug outlicensing to selling their own branded medications in Western markets within 10 to 15 years. This shift marks a strategic evolution in China's pharmaceutical industry from early-stage research to global commercialization.
SCMP Technology · 104d ago
A pharmaceutical company achieved a 1300% market cap surge despite a failed Phase III clinical trial. The article discusses strategic resilience and the importance of maintaining a 'trump card' in R&D.
钛媒体 · 107d ago
Tigermed is investing 200 million in an industrial fund despite legal investigations into its controller. The move highlights the company's heavy reliance on investment-driven growth models amid market downturns.
钛媒体 · 108d ago
A new gout innovation drug has been approved in China, ending a 13-year gap in new drug development for this condition. The article discusses the market potential and pricing strategies for this new pharmaceutical product.
钛媒体 · 108d ago
Hualan Shares' subsidiary Lingqing Zhizhi plans to invest 205 million RMB into Wuxi Natural Constant Technology. This acquisition grants the subsidiary a 34.17% stake in the company.
36氪 · 110d ago
Kanghua Biotech has officially initiated Phase II clinical trials for its self-developed lyophilized respiratory syncytial virus (RSV) mRNA vaccine. The vaccine is being developed by its subsidiary, Nameixin.
36氪 · 113d ago
Bayer is facing a class-action lawsuit alleging anti-competitive practices in the GMO corn seed market. The suit claims Bayer blocked independent companies from using its NK603 germplasm after patent expiration.
36氪 · 115d ago
Pharmaron plans to invest 3 billion yuan to build a facility for pharmaceutical intermediates and APIs in Shaoxing. The project aims to expand CDMO capacity with completion phases in 2028 and 2030.
36氪 · 115d ago
Tigermed, a leader in the CRO industry, experienced a significant stock market drop of nearly 12%. The article analyzes the causes of this financial downturn and questions the company's future viability.
钛媒体 · 122d ago
Kangle Weishi, a prominent Chinese HPV vaccine developer, is facing insolvency due to high R&D costs, excessive capital expenditure on facilities, and failed financing expectations. The company's struggle highlights the risks of the 'innovation-heavy' biotech business model.
虎嗅 · 122d ago
A small study is exploring the use of CAR-T cell therapy, typically used for cancer, to control HIV long-term. This research suggests a potential shift in how we approach chronic viral infections using immune-modulating technologies.
Wired · 124d ago
New research suggests that routine vaccinations may train the immune system in ways that protect against dementia. Experts are exploring how these immune responses could prevent cognitive decline.
Ars Technica · 127d ago
The article discusses the shifting landscape of the global innovative drug industry as we approach 2026. It highlights that the competitive environment is undergoing significant changes that many have yet to fully grasp.
钛媒体 · 127d ago
Researchers at Dartmouth Cancer Center discovered that the blood pressure medication telmisartan significantly enhances the efficacy of the cancer drug olaparib. This finding suggests a new combination therapy approach for treating certain cancers.
cnBeta (Full RSS) · 127d ago
RenDu Bio announced a major ownership transfer where Haijing Pharma will become the controlling shareholder. The deal aims to integrate diagnostic and therapeutic resources to create a comprehensive medical solution.
36氪 · 128d ago
TNM faces scrutiny over its decision to transfer the development rights of a next-generation tetanus product to Beijing Wantai Biological Pharmacy. The move raises questions about the company's core competitiveness and pipeline depth.
钛媒体 · 128d ago
Octopus Energy Generation committed $500 million to Living Carbon for reforestation on degraded land. The deal funds projects across North America to remove up to 50 million tonnes of CO₂ over 40 years.
The Next Web (TNW) · 141d ago
23andMe CEO Anne Wojcicki outlines post-reacquisition strategy leaning into direct-to-consumer model. The company, an early DTC pioneer, is not pursuing active partnerships with AI firms currently.
Bloomberg Technology · 158d ago
Tencent is targeting innovative drugs in a strategic move. This ambitious gamble by the tech giant is just beginning to unfold.
钛媒体 · 180d ago